FDA Inspection 848982 — Sciegen Pharmaceuticals Inc
The FDA completed an inspection of Sciegen Pharmaceuticals Inc on Sep 18, 2013 in Hauppauge, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 18, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hauppauge, NY (United States)